和黄医药(00013)悉数行使超额配股权涉及1560万股发售股份

智通财经2021-07-12

智通财经APP讯，和黄医药(00013)公布，联席全球协调人(代表国际包销商)已于2021年7月12日悉数行使招股章程及日期为2021年6月29日的发售价及配发结果公告所述的超额配股权，涉及合共1560万股发售股份，相当于任何超额配股权获行使前根据全球发售初步可供认购的发售股份总数约15%，以(其中包括)促使向Hutchison Healthcare Holdings Limited(长江和记...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2150407531?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89","is_english":false,"pubTime":"2021-07-12 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2150407531","market":"hk","top_or_hot":-1,"title":"和黄医药(00013)悉数行使超额配股权 涉及1560万股发售股份","media":"智通财经","content":"<div>\n<p>智通财经APP讯，和黄医药(00013)公布，联席全球协调人(代表国际包销商)已于2021年7月12日悉数行使招股章程及日期为2021年6月29日的发售价及配发结果公告所述的超额配股权，涉及合共1560万股发售股份，相当于任何超额配股权获行使前根据全球发售初步可供认购的发售股份总数约15%，以(其中包括)促使向Hutchison  Healthcare Holdings  Limited(长江和记...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/512424.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>和黄医药(00013)悉数行使超额配股权 涉及1560万股发售股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n和黄医药(00013)悉数行使超额配股权 涉及1560万股发售股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-12 23:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/512424.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，和黄医药(00013)公布，联席全球协调人(代表国际包销商)已于2021年7月12日悉数行使招股章程及日期为2021年6月29日的发售价及配发结果公告所述的超额配股权，涉及合共1560万股发售股份，相当于任何超额配股权获行使前根据全球发售初步可供认购的发售股份总数约15%，以(其中包括)促使向Hutchison  Healthcare Holdings  Limited(长江和记...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/512424.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCM","symbol_name":"和黄医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/512424.html","article_id":"2150407531","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2150407531","pubTimestamp":1626102145,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，和黄医药 公布，联席全球协调人已于2021年7月12日悉数行使招股章程及日期为2021年6月29日的发售价及配发结果公告所述的超额配股权，涉及合共1560万股发售股份，相当于任何超额配股权获行使前根据全球发售初步可供认购的发售股份总数约15%，以促使向Hutchison  Healthcare Holdings  Limited归还根据借股协议借入的股份，该等股份用于补足国际发售的超额分配。而公司将按每股发售股份40.10港元发行及配发超额配发股份。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HCM":"和黄医药","00013":"和黄医药"},"translate_title":"Hutchison Pharmaceuticals (00013) fully exercised the over-allotment shares involving 15.6 million shares for sale","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":1,"HCM":1},"content_text":"智通财经APP讯，和黄医药(00013)公布，联席全球协调人(代表国际包销商)已于2021年7月12日悉数行使招股章程及日期为2021年6月29日的发售价及配发结果公告所述的超额配股权，涉及合共1560万股发售股份，相当于任何超额配股权获行使前根据全球发售初步可供认购的发售股份总数约15%，以(其中包括)促使向Hutchison  Healthcare Holdings  Limited(长江和记实业有限公司的间接全资附属公司)归还根据借股协议借入的股份，该等股份用于补足国际发售的超额分配。而公司将按每股发售股份40.10港元(即全球发售项下每股发售股份的发售价，不包括1%经纪佣金、0.0027%证监会交易徵费及0.005%联交所交易费)发行及配发超额配发股份。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2150407531"}

和黄医药(00013)悉数行使超额配股权 涉及1560万股发售股份

精彩评论

和黄医药(00013)悉数行使超额配股权涉及1560万股发售股份